GeneralConnection.com ➔ Dictionary
Dictionary Search

niemann-pick disease

Synonyms

Noun

1. Niemann-Pick disease

2. inborn error of metabolism, lipidosis, autosomal recessive disease, autosomal recessive defect

Usage
From Neonatal Cholestasis to Progressive Neurological Impairment: A Case of Niemann-Pick Disease Type C - Cureus
Beren pockets $300m to take Niemann-Pick disease therapy to market - Pharmaceutical Technology
Biopharma bites: Beren readies for Niemann-Pick launch, layoffs at Teva, and more from Servier, Sensorion and Lilly - FirstWord Pharma
Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C - Business Wire
FDA extends adrabetadex NDA review for infantile-onset Niemann-Pick disease type C - Contemporary Pediatrics
Extracellular vesicles in Niemann pick disease type C: current knowledge and future opportunities - Frontiers
Amid Miplyffa launch, Zevra CEO aims to foster EU-style Niemann-Pick market in US - Fierce Pharma
Trappsol Cyclo Shows Promising Results in Newborns With Niemann-Pick Disease Type C1 - NeurologyLive
Niemann-Pick Type Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Inability of α-cyclodextrins to accommodate cholesterol potentially underlies their lack of efficacy and ototoxicity in Niemann-Pick disease type C treatment - Nature
Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C - BioSpace
Bowling fundraiser in Louisville supports 10-year-old’s fight against Niemann-Pick disease - WLKY
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C - The Manila Times
Beren Therapeutics Announces FDA Extension of Review Period for New Drug Application (NDA) for Adrabetadex for the Treatment of Infantile-Onset Niemann-Pick Disease, Type C - Business Wire
Hidden Burden of Lipid Accumulation: A Clinical Case of Niemann-Pick Disease - Cureus
FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease - Pharmaceutical Technology
Case Report: Interleukin-23 blockade achieves sustained remission in Niemann–Pick type C-associated Crohn’s disease refractory to anti-tumor necrosis factor therapy - Frontiers
Data Analyses Show Benefit for Individuals With Infantile-Onset Niemann-Pick Disease Type C Treated With Investigational Drug Adrabetadex - BioSpace
Beren pockets $300m to take Niemann-Pick disease therapy to market - MSN
Alexander Gold, MD, on Adrabetadex’s Impact in Infantile-Onset Niemann-Pick C - NeurologyLive
Rafael Holdings concludes Phase 3 TransportNPC™ trial for NPC - grafa.com
Niagara Falls Trip Marks Major Milestone for Children With Rare Disease - WKRC
Moving Film “Dee & Dan” Documents a Day Living With Niemann-Pick Disease as an Intimate Portrait of Resilience - Business Wire
Rafael Holdings, Inc. Announces Completion Of Last Patient Last Visit For Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo For The Treatment Of Niemann-Pick Disease Type C - marketscreener.com
Beren Therapeutics Secures $300 Million Financing To Support Potential Adrabetadex Launch - Pulse 2.0
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C - Business Wire
Zevra Therapeutics Presents Positive Data on MIPLYFFA® for Niemann-Pick Disease Type C at WORLDSymposium™ 2026 - Quiver Quantitative
IntraBio Receives European Commission Approval of AQNEURSA® for the Treatment of Niemann-Pick Type C Disease - Business Wire
Phase 3 Data Levacetylleucine Data in Niemann-Pick, FDA Requests Data for Deramiocel to Fulfill Submission, COYA 302 and Frontotemporal Dementia - NeurologyLive
FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type C - BioSpace
Niemann-Pick Disease Type C Market is Expected to Showcase - GlobeNewswire
Sharp Therapeutics Presents New Preclinical Data Supporting - GlobeNewswire
FDA delays verdict on Beren’s rare disease drug by three months - BioSpace
WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C - Yahoo Finance
Rafael Holdings completes phase 3 NPC disease trial enrollment - Investing.com UK
Rafael Holdings (RFL) completes Phase 3 TransportNPC trial - grafa.com
Beren, Through its Subsidiary Mandos, Submits New Drug Application to U.S. FDA for Adrabetadex in Infantile-Onset NPC - BioSpace
IntraBio moves to add second rare disease to Aqneursa's label - FirstWord Pharma
Parents' ‘Hearts Broke’ Learning Kids Inherited Rare Genetic Disorder (Exclusive) - People.com
Phase 3 Win for Modified Amino Acid in Rare Ataxia-Telangiectasia - Medscape
Beren Therapeutics Announces Six Presentations at the 2026 Ara Parseghian Medical Research Fund (APMRF) Conference - Business Wire
Finding Adam's voice: New Orleans mom speaks for her children with rare genetic disease - NOLA.com
IntraBio's Aqneursa, on a roll with EU approval, races toward another rare disease indication with phase 3 win - Fierce Pharma
Southern Nevada family fights rare 'childhood Alzheimer's' disease while pushing for a cure - ktnv.com
Trial of N -Acetyl- l -Leucine in Niemann–Pick Disease Type C - The New England Journal of Medicine
A dad’s plea merges with a nation’s hope as AIIMS marks Niemann-Pick awareness month - The Times of India
Recommendations for the detection and diagnosis of Niemann-Pick disease type C - Neurology® Journals
Ketogenic Diet in Niemann‐Pick Type C: Insights From a Case Report - Wiley Online Library
At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years - Nature
THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases - Business Wire
Rafael Holdings, Inc. Reports Continued Progress in Phase 3 Trial of Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 and Announces New COO - Quiver Quantitative
IntraBio Receives Regulatory Authorization to Begin Pivotal Phase III Trial of Levacetylleucine in CACNA1A-Related Disorders Across Participating Regions - Business Wire
Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression - Nature
Federal funding fight hits home for families afflicted by rare diseases - Las Vegas Sun
Tonic prime-boost of STING signalling mediates Niemann–Pick disease type C - Nature
Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease - Frontiers
Oxford mom helps get first drugs approved for treatment of a rare disease that impacts both of her sons - CT Insider
J.P. Morgan: Zevra Sees EU As Land Of Opportunity For Miplyffa - Citeline News & Insights
My son’s rare disease was renamed ASMD. Why are people still calling it Niemann-Pick? - statnews.com
Can Zevra Therapeutics (ZVRA) Turn NPC Genetic Testing Access Into a Durable Rare-Disease Edge? - Yahoo Finance
5-year-old boy approved for medication to slow rare disease - CBC
Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease - Science | AAAS
THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment - Pharmafile
IntraBio Receives Positive European Medicines Agency Opinion for Orphan Medicinal Product Designation for Acetylleucine for CACNA1A Disorders - BioSpace
Niemann-Pick Disease Type C Market Expected to Exhibit a CAGR of 17.05% During 2025-2035, Impelled by Rising Awareness and Early Diagnosis - BioSpace
Adult‐onset Niemann–Pick disease type C masquerading as spinocerebellar ataxia - Wiley Online Library
Estimated prevalence of Niemann–Pick type C disease in Quebec - Nature
Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models - Nature
FDA approves first two drugs for rare Niemann–Pick disease - Nature
Disease-Modifying, Neuroprotective Effect of N-Acetyl-l-Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C - Neurology® Journals
Signatures of natural selection and ethnic-specific prevalence of NPC1 pathogenic mutations contributing to obesity and Niemann–Pick disease type C1 - Nature
A comprehensive analysis identifies and validates NPC1 as a potential biomarker for prognosis in HCC - Frontiers
Hope for Niemann-Pick type C in FDA’s dual drug approval - Drug Discovery News
Science Update: Biomarker for Niemann-Pick type C may be useful for diagnosing other class of rare disorders, NIH study suggests - National Institutes of Health (.gov)
Necroptosis in Niemann–Pick disease, type C1: a potential therapeutic target - Nature
N-Acetyl-L-Leucine improves neurological outcomes in Niemann-Pick Disease type C - 2 Minute Medicine
Cyclo Therapeutics logs efficacy win in pivotal Niemann-Pick disease trial - Clinical Trials Arena
From genes to hope - American Society for Biochemistry and Molecular Biology
New murine Niemann-Pick type C models bearing a pseudoexon-generating mutation recapitulate the main neurobehavioural and molecular features of the disease - Nature
Sharon Hrynkow, PhD: A Look at Niemann-Pick Disease - HCPLive
Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder - Labiotech.eu
Human iNSC-derived brain organoid model of lysosomal storage disorder in Niemann–Pick disease type C - Nature
Morbidity and mortality in type B Niemann–Pick disease - Nature
ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C disease - Notre Dame News
Niemann-Pick Disease: An Approach for Diagnosis in Adulthood - Cureus
FDA Approves Zevra Therapeutics’ Arimoclomol as First Treatment for Niemann-Pick Disease Type C - NeurologyLive
FDA approves first drug for rare neuron disease, Niemann-Pick type C - statnews.com
Niemann-Pick Disease Type C Gene Therapy Gets Rare Pediatric Disease Designation - CGTLive®
Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease - Nature
Zevra Therapeutics Submits Marketing Authorization - GlobeNewswire
Human acid sphingomyelinase structures provide insight to molecular basis of Niemann–Pick disease - Nature
New report gives national voice to patients, families affected by Niemann-Pick Type C - Notre Dame News
Niemann-Pick Disease Type C Market to Reach a CAGR of 16.9% during 2024-2034, Impelled by Cyclodextrin-Based Therapies - BioSpace
Cyclo Therapeutics announces positive Niemann-Pick disease from small study - drugdiscoverytrends.com
FDA Approves Stand-Alone Therapy Levacetylleucine for Niemann-Pick Disease Type C - NeurologyLive
Additive effect of frequent polymorphism and rare synonymous variant alters splicing in twin patients with Niemann-Pick disease type C - Nature
FDA approves IntraBio’s Aqneursa to treat Niemann-Pick disease type C patients - PMLiVE
Why are people fighting over a promising treatment for a fatal childhood disease? - Science | AAAS
New drug slows Niemann–Pick disease - Nature
Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C disease - Nature
Foreign Language Equivalents
Foreign Language Equivalents of 'niemann-pick disease'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
niemann-pick diseease,   niemann-pick diseas,   niemann-pick diesase,   nirmann-pick disease,   niemann-pick dusease,   niemann-pivk disease,   neimann-pick disease,   niemann-pick disese,   niemann-pick ddisease,   niemann-pick diseaes,   niwmann-pick disease,   niemann-pick diease,   niemann-pic disease,   niemann-pic kdisease,   niemann-pick diseasse,   niemann-pick didease,   niemann-ick disease,   noemann-pick disease,   niemannn-pick disease,   niemann-pick diseasee,   niemnn-pick disease,   niemann-pick dissease,   niemann-pixk disease,   miemann-pick disease,   niemann-pcik disease,   niemann-pick diseae,   niemann--pick disease,   niemnan-pick disease,   niemannn-pick disease,   niemann-pick disaese,   niemann-pick dsease,   niiemann-pick disease,   niemann-pikc disease,   nimeann-pick disease,   biemann-pick disease,   niemsnn-pick disease,   niemann-ipck disease,   niemannp-ick disease,   niemann-picj disease,   niemann-pick idsease,   niemann-pick sisease,   niemann-pick diseaae,   niemann-pick dosease,   niemann-pick diseasw,   niemmann-pick disease,   nieman-pick disease,   niemann-picl disease,   nimann-pick disease,   nie,ann-pick disease,   niemann-pick fisease,   niemann-pick disease,   nieman-npick disease,   niemann-pickd isease,   niemann-pick diseaase,   nieamnn-pick disease,   niemann-oick disease,   niemann-pick disesse,   niemann-pick dsiease,   niemann-pck disease,   niemamn-pick disease,   niemann-pickdisease,   niemann-pick disase,   nieman-pick disease,   nemann-pick disease,   niemanm-pick disease,   niemann-pock disease,   niemann-picck disease,   iemann-pick disease,   niemann-ppick disease,   niemann-[ick disease,   inemann-pick disease,   nieann-pick disease,   niemann-puck disease,   nienann-pick disease,   niemabn-pick disease,   nieemann-pick disease,   niemann-pick diseade,   niemann-pick diisease,   niemann-pick diswase,   niemann-pick diseasr,   niemaann-pick disease,   niemanb-pick disease,   nuemann-pick disease,   niemann-piick disease,   niemann-pickk disease,   niemann-pick diaease,   niemann-pick disesae,   niemannpick disease,   niemann-pick isease,   niemann-pik disease,   niemann-pick disrase,   nniemann-pick disease
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z